These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3099116)

  • 21. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
    Schueler UH; Kolter T; Kaneski CR; Zirzow GC; Sandhoff K; Brady RO
    J Inherit Metab Dis; 2004; 27(5):649-58. PubMed ID: 15669681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
    Prence EM; Chaturvedi P; Newburg DS
    J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
    Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
    FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of membrane-bound glucosylceramide: beta-glucosidase in fibroblasts cultured from normal and glucosylceramidotic human skin.
    Mueller OT; Rosenberg A
    J Biol Chem; 1979 May; 254(9):3521-5. PubMed ID: 429368
    [No Abstract]   [Full Text] [Related]  

  • 26. The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
    Yamaguchi Y; Sasagasako N; Goto I; Kobayashi T
    J Biochem; 1994 Sep; 116(3):704-10. PubMed ID: 7852294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New aminocyclitols as modulators of glucosylceramide metabolism.
    Egido-Gabás M; Serrano P; Casas J; Llebaria A; Delgado A
    Org Biomol Chem; 2005 Apr; 3(7):1195-201. PubMed ID: 15785807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocerebrosidase deficiency and lysosomal storage of glucocerebroside induced in cultured macrophages.
    Das PK; Murray GJ; Gal AE; Barranger JA
    Exp Cell Res; 1987 Feb; 168(2):463-74. PubMed ID: 3803450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants.
    Nilsson O; Grabowski GA; Ludman MD; Desnick RJ; Svennerholm L
    Clin Genet; 1985 May; 27(5):443-50. PubMed ID: 3924448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
    Walden CM; Sandhoff R; Chuang CC; Yildiz Y; Butters TD; Dwek RA; Platt FM; van der Spoel AC
    J Biol Chem; 2007 Nov; 282(45):32655-64. PubMed ID: 17848577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytosolic beta-glucosidase in guinea pig liver cells.
    Hays WS; Wheeler DE; Eghtesad B; Glew RH; Johnston DE
    Hepatology; 1998 Jul; 28(1):156-63. PubMed ID: 9657108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
    Stephens MC; Bernatsky A; Burachinsky V; Legler G; Kanfer JN
    J Neurochem; 1978 May; 30(5):1023-7. PubMed ID: 96213
    [No Abstract]   [Full Text] [Related]  

  • 35. Saposins (sphingolipid activator proteins) in the twitcher mutant mouse.
    Shigematsu H; Morimoto S; Kishimoto Y; Weiler S; Tomich J; Barranger J; Shinohara M; Yeager AM; O'Brien JS
    J Neurochem; 1990 Nov; 55(5):1659-62. PubMed ID: 2120388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of cerebrosides and sulfatides to saposins A-D.
    Soeda S; Hiraiwa M; O'Brien JS; Kishimoto Y
    J Biol Chem; 1993 Sep; 268(25):18519-23. PubMed ID: 8360153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of beta-glucosidase from Helix pomatia by active site-directed inhibitors.
    Donsimoni R; Legler G; Bourbouze R; Lalegerie P
    Enzyme; 1988; 39(2):78-89. PubMed ID: 2969330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the possible identity of particulate beta-glucosidase and beta-xylosidase of mouse liver.
    Stephens MC; Bernatsky A; Legler G; Kanfer JN
    Biochim Biophys Acta; 1979 Nov; 571(1):70-8. PubMed ID: 40616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Glucosidase 2 (GBA2) activity and imino sugar pharmacology.
    Ridley CM; Thur KE; Shanahan J; Thillaiappan NB; Shen A; Uhl K; Walden CM; Rahim AA; Waddington SN; Platt FM; van der Spoel AC
    J Biol Chem; 2013 Sep; 288(36):26052-26066. PubMed ID: 23880767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice.
    Atsumi S; Nosaka C; Iinuma H; Umezawa K
    Arch Biochem Biophys; 1992 Sep; 297(2):362-7. PubMed ID: 1386724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.